(MENAFN- Jordan News Agency)
Amman, June 5 (Petra) -- The 3rd international conference on pharmaceuticals, entitled "The Royal Vision for Achieving Drug Security", organized by the Jordan Food and Drug Administration (JFDA) and partners, kicked off on Monday, bringing together local, Arab and foreign stakeholders from the health and pharmaceutical domains.
The two-day conference will discuss the development of the pharmacy profession, the enhancement of education outputs to keep pace with the latest developments, the empowerment of biological industries and the role of regulatory legislation in this empowerment, in addition to preparing the Jordan Center for Pharmaceutical Research (JCPR) to support this move and raise the efficiency of human resources.
Taking part in the conference are Arab health authorities from Saudi Arabia, Iraq, Algeria, Palestine and Lebanon; more than 35 speakers and 30 interlocutors from several foreign countries, such as Canada, France, the United Kingdom, Brazil, Belgium and Germany; and about 400 representatives of local and foreign drug stores and companies, health and academic institutions, the World Health Organization (WHO) and international organizations.
Director General of the JFDA Nizar Muhaidat said that the conference comes in implementation of royal directives to achieve food and drug security and improve the quality of health services provided to citizens, pointing out that the government fully supports and enables the pharmaceutical industries in Jordan to overcome difficulties.
He stressed the importance of supporting the pharmaceutical industries in Jordan to create priorities and strategies that would make the Kingdom a regional hub for the production of pharmaceutical drugs by utilizing new technologies for medicines, research and development as well as linking pharmaceutical companies.
Muhaidat pointed out that the conference is an interactive platform to discuss several topics, the most important of which is strengthening the investment environment in the field of the pharmaceutical industry through specific mechanisms in accordance with the Economic Modernization Vision.
For her part, Representative of WHO Jordan Jamela Al-Raiby said that the organization is working to support countries in strengthening their health, regulatory and control systems, stressing the importance of scientific research, development and pharmaceutical innovations, and promoting fair access to safe and effective medical products, medicines and vaccines of high quality and reasonable prices to achieve the third goal of the Sustainable Development Goals.
She added that the organization has adopted the resolutions of the World Health Assembly and provided support to most countries, including Jordan, to strengthen regulatory and oversight systems by building capacities in member states in line with best regulatory practices, regulatory cooperation and joint work, and relying on others to save time, effort and cost.
MENAFN05062023000117011021ID1106389495
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.